Renflexis 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F23AJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,565
Award facts
- Contract value 100% obligated
- $39,564.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $39,564.57 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for Renflexis 100 mg vials with an ultimate completion date of February 26, 2026.
Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the DLA Troop Support Medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F23AJ?
SPE2DR26F23AJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 25, 2026.
How much is contract SPE2DR26F23AJ worth?
The government has obligated $39,565 on SPE2DR26F23AJ.
Is contract SPE2DR26F23AJ an order under another contract?
Yes. SPE2DR26F23AJ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F23AJ competed?
The extent of competition for SPE2DR26F23AJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award